Zoetis Inc 12 Months dividend pay out ratio, in the second quarter 2026, sequentially increased to 34.15% in the second quarter 2026, ZTS's commitment to shareholders remain strong.
Within Healthcare sector 22 other companies have achieved higher 12 Months dividend pay out ratio. While in terms of ranking among all other companies, the company has moved form 676 in the first quarter 2026, to 778.
Zoetis Inc., the leading animal health company, has recently announced the declaration of a $0.432 per share dividend for the third quarter of 2024. This news comes as a testament to Zoetis' dedication to nurturing the world and advancing care for animals. The dividend is scheduled to be paid on September 4, 2024, to all shareholders of record as of July 18, 2024. Zoetis Inc. has consistently shown its strong financial resilience in recent years. In a similar press release on October 12, 2023, the company proudly declared its fourth quarter 2023 dividend, highlighting its ability to navigate challenging economic conditions and deliver value to its investors. The continuous declaration of dividends demonstrates Zoetis' commitment to its shareholders and its confidence in its financial stability.
Intro: In an exciting development for shareholders, Zoetis Inc., the world's leading animal health company, has declared its dividend for the second quarter of 2024. Despite a decrease in their dividend pay-out ratio, Zoetis Inc. continues to outperform its peers in the healthcare sector. This article will delve into the details of the announcement and assess its impact on the company's shares. Facts: 1. Zoetis Inc. (NYSE: ZTS) has declared a dividend of $0.432 per share for the second quarter of 2024. 2. The dividend will be paid on June 4, 2024, to all holders of record of the company's common stock. 3. The record date for the dividend is April 19, 2024, with the close of business as the deadline. 4. Zoetis Inc.'s 12 Months dividend pay-out ratio decreased to 50.3% in the third quarter of 2023. 5. Despite the decline, Zoetis Inc.'s current dividend pay-out ratio remains above its average of 32.96%. 6. Within the healthcare sector, 21 companies have a higher 12 Months dividend pay-out ratio than Zoetis Inc. 7. Zoetis Inc. ranks higher than 478 out of all other companies in the second quarter of 2023.
In a recent press release, Zoetis Inc., a leading global animal health company, has declared a dividend of $0.432 per share for the first quarter of 2024. This marks a significant 15% increase from the previous quarterly dividend rate paid in 2023. The dividend is scheduled to be paid on March 1, 2024, to all holders of record as of January 19, 2024. The decision to increase the dividend reflects Zoetis' continued strong performance, thanks to its diverse and innovative product portfolio. With its ongoing commitment to delivering high-quality animal health solutions, the company has consistently achieved impressive results.
Zoetis Inc., the world's leading animal health company, has declared a quarterly dividend of $0.375 per share for the fourth quarter of 2023. The dividend payout is a testament to the company's commitment to nurturing the world and advancing care for animals. This article will provide an overview of the dividend announcement and analyze Zoetis's financial performance. Dividend Details: The dividend will be paid on Friday, December 1, 2023, to all holders of record of Zoetis's common stock as of the close of business on Wednesday, November 1, 2023. Despite an increase in earnings per share in the second quarter of 2023, Zoetis's 12-month dividend payout ratio sequentially decreased to 50.96%. However, the ratio still remains above average, indicating the company's strong cash flow.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
